Zydus Lifesciences Ltd
NSE:ZYDUSLIFE

Watchlist Manager
Zydus Lifesciences Ltd Logo
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
Watchlist
Price: 859.65 INR -2.31% Market Closed
Market Cap: 865B INR
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+10%
Revenue
Forecast
+35%
Operating Income
Forecast
+34%
Net Income
Forecast
+31%

Wall Street
Price Targets

ZYDUSLIFE Price Targets Summary
Zydus Lifesciences Ltd

Wall Street analysts forecast ZYDUSLIFE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ZYDUSLIFE is 1 067.94 INR with a low forecast of 811.03 INR and a high forecast of 1 433.25 INR.

ZYDUSLIFE Lowest Forecast
Wall Street Target
811.03 INR
6% Downside
ZYDUSLIFE Average Forecast
Wall Street Target
1 067.94 INR
24% Upside
ZYDUSLIFE Highest Forecast
Wall Street Target
1 433.25 INR
67% Upside
Lowest
Price Target
811.03 INR
6% Downside
Average
Price Target
1 067.94 INR
24% Upside
Highest
Price Target
1 433.25 INR
67% Upside
Zydus Lifesciences Ltd Competitors:
Price Targets
603998
Hunan Fangsheng Pharmaceutical Co Ltd
47% Upside
1177
Sino Biopharmaceutical Ltd
22% Upside
SNDL
Sundial Growers Inc
140% Upside
PFE
Pfizer Inc
30% Upside
603998
Hunan Fangsheng Pharmaceutical Co Ltd
47% Upside
1177
Sino Biopharmaceutical Ltd
22% Upside
SNDL
Sundial Growers Inc
140% Upside
PFE
Pfizer Inc
30% Upside
IOLCP
IOL Chemicals and Pharmaceuticals Ltd
34% Upside
ANIP
ANI Pharmaceuticals Inc
19% Upside
PAHC
Phibro Animal Health Corp
8% Upside
INDOCO
Indoco Remedies Ltd
38% Upside

Revenue
Forecast

Revenue Estimate
Zydus Lifesciences Ltd

For the last 8 years the compound annual growth rate for Zydus Lifesciences Ltd's revenue is 9%. The projected CAGR for the next 4 years is 9%.

9%
Past Growth
9%
Estimated Growth
Estimates Accuracy
0%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Zydus Lifesciences Ltd

For the last 8 years the compound annual growth rate for Zydus Lifesciences Ltd's operating income is 11%. The projected CAGR for the next 4 years is 4%.

11%
Past Growth
4%
Estimated Growth
Estimates Accuracy
1%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Zydus Lifesciences Ltd

For the last 8 years the compound annual growth rate for Zydus Lifesciences Ltd's net income is 9%. The projected CAGR for the next 4 years is 3%.

9%
Past Growth
3%
Estimated Growth
Estimates Accuracy
8%
Average Beat
What are analyst estimates?

See Also

Summary
ZYDUSLIFE intrinsic value, competitors valuation, and company profile.
DCF Valuation
ZYDUSLIFE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ZYDUSLIFE stock valuation using valuation multiples.
Wall Street Estimates
ZYDUSLIFE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ZYDUSLIFE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ZYDUSLIFE's stock price target?
Price Target
1 067.94 INR

According to Wall Street analysts, the average 1-year price target for ZYDUSLIFE is 1 067.94 INR with a low forecast of 811.03 INR and a high forecast of 1 433.25 INR.

What is Zydus Lifesciences Ltd's Revenue forecast?
Projected CAGR
9%

For the last 8 years the compound annual growth rate for Zydus Lifesciences Ltd's revenue is 9%. The projected CAGR for the next 4 years is 9%.

What is Zydus Lifesciences Ltd's Operating Income forecast?
Projected CAGR
4%

For the last 8 years the compound annual growth rate for Zydus Lifesciences Ltd's operating income is 11%. The projected CAGR for the next 4 years is 4%.

What is Zydus Lifesciences Ltd's Net Income forecast?
Projected CAGR
3%

For the last 8 years the compound annual growth rate for Zydus Lifesciences Ltd's net income is 9%. The projected CAGR for the next 4 years is 3%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 250,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.